Effects Of Portal Hypertension In Rats Reversed By Combination Therapy, Promising Implications For Human Patients

A combined treatment with rapamycin and Gleevec might reverse the effects of portal hypertension in patients with chronic liver disease, according to the results of a new study on rats. The study is in the October issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at [click link for full article]

More: continued here

Filed under: Biology on October 5th, 2007